Profound Medical
PROF
35 hedge funds and large institutions have $35.6M invested in Profound Medical in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 12 increasing their positions, 10 reducing their positions, and 5 closing their positions.
1,217% more call options, than puts
Call options by funds: $1.7M | Put options by funds: $129K
20% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 10
0.36% more ownership
Funds ownership: 41.76% → 42.12% (+0.36%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
10% less funds holding
Funds holding: 39 → 35 (-4)
44% less capital invested
Capital invested by funds: $63M → $35.6M (-$27.5M)
80% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
National Bank of Canada
Montreal,
Quebec, Canada
|
+$5.25M |
| 2 |
GS
Gagnon Securities
New York
|
+$2.97M |
| 3 |
GA
Gagnon Advisors
New York
|
+$1.4M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$662K |
| 5 |
Fidelity International
Hamilton,
Bermuda
|
+$101K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$6.62M |
| 2 |
TIM
Timelo Investment Management
Aurora,
Ontario, Canada
|
-$1.38M |
| 3 |
PIC
PCJ Investment Counsel
Toronto,
Ontario, Canada
|
-$811K |
| 4 |
AIC
AWM Investment Company
New York
|
-$626K |
| 5 |
RA
Royce & Associates
New York
|
-$391K |
PROF Hedge Fund Activity: Q3 2022 in Review
35 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in Profound Medical (PROF) for Q3 2022, worth a combined $35.6M — down 44% from $63M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of PROF and 1 opened new positions — a net loss of 4 holders — while 10 trimmed existing stakes and 12 added.
The largest buyer was National Bank of Canada, adding an estimated $5.25M. The largest seller was Deerfield Management, cutting an estimated $6.62M.
- 35 institutional investors held Profound Medical (PROF) as of Q3 2022, down from 39 in Q2 2022.
- Funds reported $35.6M of Profound Medical stock for Q3 2022, down 44% quarter-over-quarter.
- 1 fund opened new Profound Medical positions in Q3 2022 and 5 closed out, a net change of -4 holders.
- The largest Profound Medical buyer in Q3 2022 was National Bank of Canada, an estimated $5.25M added.
- The largest Profound Medical seller in Q3 2022 was Deerfield Management, an estimated $6.62M sold.
Based on aggregated 13F filings for Q3 2022.